Solid Biosciences Statistics
Total Valuation
SLDB has a market cap or net worth of $950.02 million. The enterprise value is $592.49 million.
| Market Cap | 950.02M |
| Enterprise Value | 592.49M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SLDB has 107.23 million shares outstanding. The number of shares has increased by 80.98% in one year.
| Current Share Class | 107.23M |
| Shares Outstanding | 107.23M |
| Shares Change (YoY) | +80.98% |
| Shares Change (QoQ) | +30.85% |
| Owned by Insiders (%) | 0.91% |
| Owned by Institutions (%) | 66.94% |
| Float | 64.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.55 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.82, with a Debt / Equity ratio of 0.05.
| Current Ratio | 13.82 |
| Quick Ratio | 13.21 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -65.50% and return on invested capital (ROIC) is -39.25%.
| Return on Equity (ROE) | -65.50% |
| Return on Assets (ROA) | -36.38% |
| Return on Invested Capital (ROIC) | -39.25% |
| Return on Capital Employed (ROCE) | -54.12% |
| Weighted Average Cost of Capital (WACC) | 17.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.71M |
| Employee Count | 121 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.49% in the last 52 weeks. The beta is 2.42, so SLDB's price volatility has been higher than the market average.
| Beta (5Y) | 2.42 |
| 52-Week Price Change | +32.49% |
| 50-Day Moving Average | 8.65 |
| 200-Day Moving Average | 6.94 |
| Relative Strength Index (RSI) | 52.77 |
| Average Volume (20 Days) | 906,897 |
Short Selling Information
The latest short interest is 17.04 million, so 15.89% of the outstanding shares have been sold short.
| Short Interest | 17.04M |
| Short Previous Month | 17.67M |
| Short % of Shares Out | 15.89% |
| Short % of Float | 26.29% |
| Short Ratio (days to cover) | 12.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -212.15M |
| Pretax Income | -207.10M |
| Net Income | -207.10M |
| EBITDA | -210.52M |
| EBIT | -212.15M |
| Earnings Per Share (EPS) | -$1.87 |
Balance Sheet
The company has $377.68 million in cash and $20.16 million in debt, with a net cash position of $357.52 million or $3.33 per share.
| Cash & Cash Equivalents | 377.68M |
| Total Debt | 20.16M |
| Net Cash | 357.52M |
| Net Cash Per Share | $3.33 |
| Equity (Book Value) | 374.08M |
| Book Value Per Share | 3.56 |
| Working Capital | 366.52M |
Cash Flow
In the last 12 months, operating cash flow was -$186.84 million and capital expenditures -$965,000, giving a free cash flow of -$187.81 million.
| Operating Cash Flow | -186.84M |
| Capital Expenditures | -965,000 |
| Depreciation & Amortization | 1.63M |
| Net Borrowing | -446,000 |
| Free Cash Flow | -187.81M |
| FCF Per Share | -$1.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -80.98% |
| Shareholder Yield | -80.98% |
| Earnings Yield | -21.27% |
| FCF Yield | -19.29% |
Analyst Forecast
The average price target for SLDB is $17.64, which is 99.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.64 |
| Price Target Difference | 99.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 28, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Oct 28, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |